Key statistics
On Friday, INCYTE CORP DRN (I1NC34:SAO) closed at 207.00, -10.85% below its 52-week high of 232.20, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 205.50 |
---|---|
High | 208.00 |
Low | 205.50 |
Bid | 207.20 |
Offer | 208.60 |
Previous close | 232.20 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 20:54 GMT.
More ▼
Press releases
- Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
- Incyte to Present at Upcoming Investor Conference
- Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Incyte to Present at Upcoming Investor Conferences
- Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
- Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top Employers List
- Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program
- Incyte to Report Third Quarter Financial Results
- Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
More ▼